Nacuity Pharmaceuticals
Biotechnology, 306 W 7th St Ste 310, Fort Worth, Texas, 76102, United States, 11-50 Employees
Phone Number: 81********
Who is NACUITY PHARMACEUTICALS
Nacuity Pharmaceuticals is a clinical-stage leader in innovative treatments for oxidative stress. The companys powerful, targeted therapies aim to stop oxidative tissue damage, a driver o...
Read More
-
Headquarters: 306 W 7th St Ste 310, Fort Worth, Texas, 76102, United States
-
Date Founded: 2017
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 32 |
Show More
Does something look wrong? Fix it. | View contact records from NACUITY PHARMACEUTICALS
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nacuity Pharmaceuticals
Answer: Nacuity Pharmaceuticals's headquarters are located at 306 W 7th St Ste 310, Fort Worth, Texas, 76102, United States
Answer: Nacuity Pharmaceuticals's phone number is 81********
Answer: Nacuity Pharmaceuticals's official website is https://nacuity.com
Answer: Nacuity Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Nacuity Pharmaceuticals's SIC: 2834
Answer: Nacuity Pharmaceuticals's NAICS: 32
Answer: Nacuity Pharmaceuticals has 11-50 employees
Answer: Nacuity Pharmaceuticals is in Biotechnology
Answer: Nacuity Pharmaceuticals contact info: Phone number: 81******** Website: https://nacuity.com
Answer: Nacuity Pharmaceuticals is a clinical-stage leader in innovative treatments for oxidative stress. The companys powerful, targeted therapies aim to stop oxidative tissue damage, a driver of many blinding eye diseases and a broad spectrum of serious chronic conditions. Powered by key backing and technical support from the worlds leading private funders of retinal disease research, Foundation Fighting Blindness and RD Fund, Nacuity is pursuing near-term proof-of-concept data in several of its highly differentiated clinical programs, including retinitis pigmentosa, cataract, and cystinosis, with the potential to be first-of-a-kind therapies and gateways to wider applications.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month